GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...

A unique collaboration between electrical engineers and ophthalmologists solves clinical, computational challenges.

A new study suggests popular weight-loss drugs like Ozempic and Zepbound may be linked to rare eye conditions that could ...

Ed Mahon reported this story while participating in the USC Annenberg Center for Health Journalism’s 2024 Data Fellowship and received engagement mentoring and funding. Spotlight PA is ...